We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Application Fees Going Up for Rx Drugs, Down for Biosimilars in 2018
Application Fees Going Up for Rx Drugs, Down for Biosimilars in 2018
Application fees for prescription drug approvals will increase by nearly 20 percent in fiscal 2018, starting Oct. 1, the FDA said in a Federal Register filing.